Rapid Flu Test

Overview

Documentation

Order Inquiry

Select Product:

Annual Analytical Sensitivity Report

Is Your Flu Test Hitting the Target?

Meets the FDA's New Rapid Antigen Detection Tests (RIDTs) reclassification requirements?
Has demonstrated analytical sensitivity for CDC's 2020-2021 flu strain panels?
Is CLIA-waived?

Sensitivity to Meet Your Needs

OraSure QuickFlu® is an FDA cleared, CLIA-waived in vitro rapid qualitative test for the detection and differentiation of influenza type A and type B. An easy nasal swab procedure provides accurate results in as little as 10 minutes.

Orasure QuickFlu® delivers highly accurate results for flu types A and B and meets FDA's new standards of performance.

Proven analytical sensitivity across 51 different flu strains including CDC's 2020-2021 flu strain panels (There is a delay with the 2021 annual reactivity data due to COVID. We will post the updated reactivity data chart as soon its available.)
Exceptional correlation to culture/PCR

Proven Performance That Meets FDA's Reclassification Rules

OraSure QuickFlu® exceeds the FDA's reclassification requirement minimums for RIDTs.

As of February 13, 2017, all RIDTs must meet the minimum acceptance performance criteria and comparator method for antigen based RIDTs. Tests that do not meet the new requirements cannot be used.
Analytical reactivity testing must be performed on contemporary influenza strains and newly emerging strains in the event of an emergency.

Ensures Responsive Standard of Care

Simple, easy-to-use procedure with built-in control line
Includes a flocked swab that optimizes sample collection and release resulting in superior performance
- American Society of Microbiology says, "NP flocked swabs collect better samples than routine NP swabs"
Nasal swab collection – comfortable for the patient and simple for the HCP with no ancillary supplies required
Ready-to-use reagents with room temperature storage
Rapid testing that maximizes results

Test at the Point of Care

OraSure QuickFlu® is ideal for testing at the point of care in...

Laboratories
Emergency Rooms
Physician Offices
Public Health Facilities and Clinics

Reimbursement Information

CPT Codes

87804 QW- Influenza A Detection

87804-59- Influenza B Detection

In-Depth Product Details

Do you need detailed information about our products? Use these resources.

Request more product information »

*OraSure provides information regarding reimbursement (including, in some instances, potentially applicable CPT, HCPCS and/or analogous state or local codes or designations) for background purposes only. It does not constitute legal advice or a recommendation regarding clinical practice. Information provided is gathered from third-party sources and is subject to change without notice. The provider has the responsibility to determine medical necessity and to submit appropriate codes and charges for care provided. Any decision regarding specific coding is at the discretion of the healthcare professional, and provision of this information does not guarantee or facilitate reimbursement. OraSure makes no guarantee that the use of this information will prevent differences of opinion or disputes with Medicare or other payers as to the correct form of billing or the amount that will be paid to providers of service. Please contact your Medicare contractor, insurance provider, other payers, reimbursement specialists and/or legal counsel for interpretation of coding, coverage and payment policies or specific billing questions or concerns. Nothing herein is intended to promote or facilitate the purchase or use of products outside of their approved or cleared indications, and appropriate use of products should be based on the healthcare professional’s medical judgment.